A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin

NCT01492361 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

8179

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Diseases

Interventions

DRUG: AMR101
DRUG: Placebo
DRUG: Statin therapy

Sponsor

Amarin Pharma Inc.